Copyright © 2015 Fabiani Bogorni et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. One-third to half of patients taking clozapine suffer from refractory symptoms despite adequate treatment. Among other adverse effects, clozapine-induced hypersalivation (CIH) occurs in approximately half of all patients. This is a case of a 30-year-old male with refractory schizophrenia; in this patient, the remission of residual positive symptoms, as well as the reduction of CIH, was achieved by treatment with clozapine augmented with amisulpride. 1
Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related ...
BACKGROUND: Clozapine is the only medication approved for those patients with schizophrenia who do n...
One of the most stimulating problems posed by second generation antipsychotics is the question of wh...
Clozapine-induced sialorrhea (CIS) affects about one-third of patients treated with clozapine, at ti...
BACKGROUND: The clinical outcome of patients suffering from schizophrenic psychoses has been conside...
Background: The common practice of augmenting the efficacy of clozapine by addition of amisulpride h...
Background: Therapeutic options for patients with treatment-resistant schizophrenia are limited. In ...
Amisulpride is an atypical antipsychotic with a significantly greater effect size than first-generat...
Background: A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia,...
IntroductionSchizophrenia is regarded as one of the most severe, disabling, and costly mental illnes...
Background: When treatment-refractory schizophrenia shows an insufficient response to a trial of clo...
Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersa...
In this article, our aim was to share our clinical experience regarding the effectiveness and the si...
Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea TO TH...
Amisulpride is a bezamide group of antipsychotic, and like other antipsychotics, it acts by reducing...
Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related ...
BACKGROUND: Clozapine is the only medication approved for those patients with schizophrenia who do n...
One of the most stimulating problems posed by second generation antipsychotics is the question of wh...
Clozapine-induced sialorrhea (CIS) affects about one-third of patients treated with clozapine, at ti...
BACKGROUND: The clinical outcome of patients suffering from schizophrenic psychoses has been conside...
Background: The common practice of augmenting the efficacy of clozapine by addition of amisulpride h...
Background: Therapeutic options for patients with treatment-resistant schizophrenia are limited. In ...
Amisulpride is an atypical antipsychotic with a significantly greater effect size than first-generat...
Background: A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia,...
IntroductionSchizophrenia is regarded as one of the most severe, disabling, and costly mental illnes...
Background: When treatment-refractory schizophrenia shows an insufficient response to a trial of clo...
Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersa...
In this article, our aim was to share our clinical experience regarding the effectiveness and the si...
Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea TO TH...
Amisulpride is a bezamide group of antipsychotic, and like other antipsychotics, it acts by reducing...
Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related ...
BACKGROUND: Clozapine is the only medication approved for those patients with schizophrenia who do n...
One of the most stimulating problems posed by second generation antipsychotics is the question of wh...